Synlogic, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SYBX Company Description
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
SYBX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SYBX Smart Score
Score Breakdown
SYBX Company Description
Show More
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SYBX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SYBX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on SYBX's company Twitter account
WallStreetBets
Number of mentions of SYBX in WallStreetBets Daily Discussion
SYBX News
Recent insights relating to SYBX
CNBC Recommendations
Recent picks made for SYBX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SYBX
Corporate Flights
Flights by private jets registered to SYBX
Our Analysis